evaluation of chemerin in diabetic type 2 patients with metabolic syndrome in both gender

Aims: chemerin abnormal level represents a risk indicator of visceral fat increase. it has a role in the incidence of inflammation, insulin resistance, metabolic syndrome, obesity, and diabetes. this study aimed to evaluate chemerin level in diabetic type 2 patients with metabolic syndrome in both genders. materials & methods: this study was carried out on the patients referred to the al-yarmouk teaching hospital in 2021-2022. 88 participants were selected by random sampling method and were divided into two groups including t2dm patients with metabolic syndrome in the experience group (n=55) compared with healthy subjects in the control group (n=38). triacylglycerol (tg), high-density lipoprotein-cholesterol (hdl-c), obesity (bmi), serum chemerin, hypertension (sbp), age, fasting blood glucose (fbg), and glycated haemoglobin (hba1c) were measured in the two studied groups. data were analyzed using t-test through spss 21 software.findings: a significant difference was observed between the levels of bmi, sbp, fbg, tg, hdl-c, chemerin weight, dbp, and hba1c in the studied groups (p=0.05). the rate of wc and hdl-c was higher in the females than in males in the experience group. while, there was a significant increase in the rates of sbp, fbg, tg, and chemerin in males than females. a positive correlation coefficient was observed between age, sbp, wc, bmi, fbg, tg, and hba1c with chemerin level in the experience group. conclusion: an increase in chemerin level is associated with a high level of triglycerides during the onset of symptoms of metabolic syndrome, age, and gender, which affect the increase of adipokine.